We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ali Khaki

Ali Raza Khaki MD

Clinical Assistant Professor of Medicine|Oncology, Stanford University School of Medicine, Palo Alto, California

Dr. Khaki is a hematologist/oncologist with board certification in oncology, hematology, and internal medicine. He is also a clinical assistant professor of oncology at Stanford University School of Medicine.

In his clinical practice, he treats patients all forms of genitourinary cancer, including kidney, bladder, prostate, and testicular. With each patient, he is devoted to providing exceptional, humanistic care. As a medical student, he was named to the national Gold Humanism Honor Society. As a resident, he received the Reza Gandjei Humanism Award.

His research interests include novel therapies for genitourinary cancers, with a focus on urothelial cancer outcomes. He also has studied health care utilization and costs for end-of-life care of cancer patients.

Dr. Khaki has earned honors and recognition from the American Association for Cancer Research, American Society of Clinical Oncology, Bladder Cancer Advocacy Network, Conquer Cancer Foundation, and other organizations.

He has authored numerous articles on topics such as immunotherapy for urothelial cancer, management of cancer patients with COVID-19, and utilization of end-of-life care by cancer patients. His work has appeared in publications including JAMA Oncology, Cancer Investigation, Clinical Genitourinary Cancer, the Journal of Urology, and Lancet. In addition, he is an editor for HemOnc.org and theMednet, the physician-only online community where members share clinical questions and answers.